AU1854901A - Novel method - Google Patents
Novel methodInfo
- Publication number
- AU1854901A AU1854901A AU18549/01A AU1854901A AU1854901A AU 1854901 A AU1854901 A AU 1854901A AU 18549/01 A AU18549/01 A AU 18549/01A AU 1854901 A AU1854901 A AU 1854901A AU 1854901 A AU1854901 A AU 1854901A
- Authority
- AU
- Australia
- Prior art keywords
- novel method
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9925559 | 1999-10-28 | ||
GBGB9925559.8A GB9925559D0 (en) | 1999-10-28 | 1999-10-28 | Novel method |
PCT/EP2000/010733 WO2001030390A2 (en) | 1999-10-28 | 2000-10-27 | Method |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1854901A true AU1854901A (en) | 2001-05-08 |
Family
ID=10863574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU18549/01A Abandoned AU1854901A (en) | 1999-10-28 | 2000-10-27 | Novel method |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1223987A2 (en) |
JP (1) | JP2003512440A (en) |
AU (1) | AU1854901A (en) |
CA (1) | CA2388995A1 (en) |
GB (1) | GB9925559D0 (en) |
WO (1) | WO2001030390A2 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2375704T5 (en) * | 2000-06-29 | 2016-03-03 | Smithkline Beecham Biologicals S.A. | Composition of multivalent vaccine |
KR100947751B1 (en) | 2001-01-23 | 2010-03-18 | 아벤티스 파스퇴르 | Multivalent meningococcal polysaccharide-protein conjugate vaccine |
GB0115176D0 (en) | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
GB0211118D0 (en) * | 2002-05-15 | 2002-06-26 | Polonelli Luciano | Vaccines |
EP2351579B1 (en) | 2002-10-11 | 2016-09-21 | Novartis Vaccines and Diagnostics S.r.l. | Polypeptide vaccines for broad protection against hypervirulent meningococcal lineages |
GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
ATE552844T1 (en) | 2003-01-30 | 2012-04-15 | Novartis Ag | INJECTABLE VACCINE AGAINST MULTIPLE MENINGOCOCC SEROGROUPES |
BR122017002991B1 (en) | 2003-10-02 | 2023-01-10 | Novartis Vaccines And Diagnostics S.R.L. | AQUEOUS IMMUNOGENIC COMPOSITIONS FOR MULTIPLE MENINGOCOCCAL SEROGROUPS |
GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
BRPI0417689A8 (en) | 2003-12-17 | 2017-04-25 | Elan Pharm Inc | METHOD FOR CONJUGATING A PEPTIDE IMMOGEN, COMPOSITION, CONJUGATE, IMMUNOGENIC COMPOSITION, METHOD FOR INDUCING AN IMMUNE RESPONSE IN A MAMMAL INDIVIDUAL, AND, USE OF THE CONJUGATE |
SI1896065T2 (en) | 2005-06-27 | 2014-12-31 | Glaxosmithkline Biologicals S.A. | Process for manufacturing vaccines |
GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
ES2383209T3 (en) | 2006-03-22 | 2012-06-19 | Novartis Ag | Regimens for immunization with meningococcal conjugates |
US10828361B2 (en) | 2006-03-22 | 2020-11-10 | Glaxosmithkline Biologicals Sa | Regimens for immunisation with meningococcal conjugates |
CA2662051A1 (en) | 2006-09-07 | 2008-03-13 | Glaxosmithkline Biologicals S.A. | Vaccine |
UY31064A1 (en) | 2007-05-02 | 2009-01-05 | Glaxosmithkline Biolog Sa | VACCINE |
GB0713880D0 (en) | 2007-07-17 | 2007-08-29 | Novartis Ag | Conjugate purification |
CN101951949B (en) | 2007-10-19 | 2013-10-02 | 诺华股份有限公司 | Meningococcal vaccine formulations |
EP2886551A3 (en) | 2008-02-21 | 2015-09-23 | Novartis AG | Meningococcal fhbp polypeptides |
NZ593674A (en) | 2008-12-17 | 2013-03-28 | Novartis Ag | Meningococcal vaccines including hemoglobin receptor |
JP5668049B2 (en) | 2009-03-24 | 2015-02-12 | ノバルティス アーゲー | Combination of meningococcal factor H binding protein and pneumococcal saccharide conjugate |
CA2772104A1 (en) | 2009-08-27 | 2011-03-03 | Novartis Ag | Hybrid polypeptides including meningococcal fhbp sequences |
AU2010302344A1 (en) | 2009-09-30 | 2012-04-26 | Novartis Ag | Expression of meningococcal fhbp polypeptides |
MX2012004850A (en) | 2009-10-27 | 2012-05-22 | Novartis Ag | Modified meningococcal fhbp polypeptides. |
EP2613805B1 (en) | 2010-09-10 | 2019-10-23 | GlaxoSmithKline Biologicals SA | Meningococcus overexpressing nada and/or nhba and outer membrane vesicles derived therefrom |
WO2012153302A1 (en) | 2011-05-12 | 2012-11-15 | Novartis Ag | Antipyretics to enhance tolerability of vesicle-based vaccines |
CN102507924B (en) * | 2011-11-17 | 2014-06-18 | 成都欧林生物科技股份有限公司 | Method for detecting concentration of polysaccharide in zymotic fluid |
JP5957541B2 (en) | 2012-02-02 | 2016-07-27 | ノバルティス アーゲー | Promoter for increased protein expression in Neisseria meningitidis |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5604108A (en) * | 1992-09-14 | 1997-02-18 | Connaught Laboratories, Inc. | Test for determining the dose response of a conjugated vaccine |
GB9727262D0 (en) * | 1997-12-24 | 1998-02-25 | Smithkline Beecham Biolog | Vaccine |
JP2002540074A (en) * | 1999-03-19 | 2002-11-26 | スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム | vaccine |
-
1999
- 1999-10-28 GB GBGB9925559.8A patent/GB9925559D0/en not_active Ceased
-
2000
- 2000-10-27 WO PCT/EP2000/010733 patent/WO2001030390A2/en not_active Application Discontinuation
- 2000-10-27 CA CA002388995A patent/CA2388995A1/en not_active Abandoned
- 2000-10-27 AU AU18549/01A patent/AU1854901A/en not_active Abandoned
- 2000-10-27 EP EP00981226A patent/EP1223987A2/en not_active Withdrawn
- 2000-10-27 JP JP2001532807A patent/JP2003512440A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2388995A1 (en) | 2001-05-03 |
EP1223987A2 (en) | 2002-07-24 |
WO2001030390A3 (en) | 2002-04-04 |
GB9925559D0 (en) | 1999-12-29 |
WO2001030390A2 (en) | 2001-05-03 |
JP2003512440A (en) | 2003-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1854901A (en) | Novel method | |
AU1173201A (en) | Skin-gripper | |
AU3092999A (en) | Digital-timeshare-exchange | |
AU1538901A (en) | Polymersation process | |
AU4115400A (en) | Short-circuiter | |
AU2804600A (en) | Arylaminoalkylamides | |
AU2023701A (en) | Sketcher | |
AU6098300A (en) | Follistatin-3 | |
AU4916900A (en) | Benzofuranylsulfonates | |
AU7273000A (en) | Novel processes | |
AU2359301A (en) | Novel ss-defensins | |
AU4561600A (en) | Benzofuranylaminoalcohols | |
AU1038501A (en) | Novel processes | |
AU1901801A (en) | Glucofuranoses | |
AU1915601A (en) | Periotome | |
AU2582200A (en) | Windturbine | |
AU4435300A (en) | Hula-hoop | |
AU5552200A (en) | Method | |
AU6169100A (en) | Novel process | |
AU1165801A (en) | Novel process | |
AU5550700A (en) | Novel process | |
AU2290401A (en) | Novel processes | |
AU4585100A (en) | Method | |
AU2197301A (en) | Microlamp | |
AU5416100A (en) | Retinoscopes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |